Valneva logo

Valneva

Specialty vaccine company focused on prevention of infectious diseases with major unmet need, such as Lyme & chikungunya

637 employees · est. 2013 · Saint-herblain, France

VS
Walvax logo

Walvax

Help everyone live a healthy life!

79 employees · est. 2001 · Kunming, China

Walvax is the older company (2013 vs 2001); Valneva is the larger of the two.

Side-by-Side Comparison

Valneva Walvax
Founded
2013 2001 older
Headquarters
Saint-herblain, France Kunming, China
Employees
637 larger 79
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health Care, Pharmaceutical
Funding Stage
Grant Post Ipo Equity
Total Funding
$720.10M $72.80M
Funding Rounds
15 1
Services
Vaccine Research and Development, Manufacturing of Vaccines, Commercialization of Vaccines, Marketing and Distribution Not tracked yet
Target Customers
Healthcare Providers, Travelers, Health Organizations, Governments, Investors Not tracked yet
Taxonomy
Specialty Vaccines, Infectious Disease Prevention, Prophylactic Vaccines, Vaccine Modalities, First-in-Class Vaccines, Only-in-Class Vaccines, Lyme Disease Vaccine, Chikungunya Vaccine, Travel Vaccines, Vaccine R&D, Vaccine Manufacturing, Clinical Development, Public Health Threats, Pfizer Partnership, Zika Virus Vaccine Biological Pharmaceutical Company, Vaccines, Blood Products, Biomedicine Products, Meningococcal Polysaccharide Vaccine, Haemophilus Influenzae Type B Conjugate Vaccine, Infectious Diseases, Preventive Healthcare, Public Health, Research And Development, Bio-medicine, Medical Innovation, China, Kunming
Website
valneva.com en.walvax.com
Valneva logo

About Valneva

Valneva, founded in 2013, is a France-based specialty vaccine company renowned for addressing infectious diseases with significant unmet needs. With a forward-thinking approach, the company prides itself on offering first-, best-, or only-in-class vaccine solutions. Their portfolio includes the worl...

Walvax logo

About Walvax

Walvax is a biotechnology company founded in 2001, with a mission to "Help everyone live a healthy life!" Headquartered in Kunming, China, the company went public via IPO in 2010 (300142.SZ). Ever since, the company has been expanding from traditional vaccines to innovative vaccines. With a focus on...

We will tell you when either one moves

BounceWatch watches Valneva and Walvax for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Valneva and Walvax — by email.

Frequently Asked Questions

Valneva — Specialty vaccine company focused on prevention of infectious diseases with major unmet need, such as Lyme & chikungunya. Walvax — Help everyone live a healthy life!. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Valneva has raised $720.10M while Walvax has raised $72.80M.
Valneva and Walvax operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Valneva with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Valneva on 11 Mar 2026, and Walvax on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy